Glioblastoma: all 1,951 studies
Page 13 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBMActive, not recruitingNCT03862430Phase 2
- Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor CellsTerminatedNCT03861598Early Phase 1
- TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on BevacizumabTerminatedNCT03856099Phase 2
- 131I-IPA and Concurrent XRT in Recurrent GBMCompletedNCT03849105Phase 1/2
- Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent GlioblastomaCompletedNCT03782415Phase 1/2
- TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBMStatus unknownNCT03780569Not applicable
- A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1CompletedNCT03776071Phase 3
- Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in GlioblastomaCompletedNCT03770468
- VXM01 Plus Avelumab Combination Study in Progressive GlioblastomaStatus unknownNCT03750071Phase 1/2
- BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV GliomasActive, not recruitingNCT03749187Phase 1
- To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)Status unknownNCT03746288Phase 2
- Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9CompletedNCT03744026Phase 1/2
- Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated GlioblastomaActive, not recruitingNCT03743662Phase 2
- Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaCompletedNCT03739372Not applicable
- Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.Status unknownNCT03739333Not applicable
- A Phase 1 Study of ZSP1602 in Participants With Advanced Solid TumorsStatus unknownNCT03734913Phase 1
- 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent GlioblastomaCompletedNCT03732352Phase 2
- CART-EGFRvIII + Pembrolizumab in GBMCompletedNCT03726515Phase 1
- Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant GliomaCompletedNCT03722355Phase 3
- TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent GlioblastomaStatus unknownNCT03722342Phase 1
- Feasibility of the LUM Imaging System for Detection of Cancer to the BrainTerminatedNCT03717142Not applicable
- DNX-2440 Oncolytic Adenovirus for Recurrent GlioblastomaTerminatedNCT03714334Phase 1
- ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard ChemotherapyCompletedNCT03712293Not applicable
- Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of GlioblastomaTerminatedNCT03707457Phase 1
- DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without VarlilumabActive, not recruitingNCT03688178Phase 2
- Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human GlioblastomaCompletedNCT03687099
- A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With GlioblastomaStatus unknownNCT03687034Phase 1
- Feasibility of Individualized Therapy for Recurrent GlioblastomaCompletedNCT03681028Phase 1
- A Trial of Ipatasertib in Combination With AtezolizumabActive, not recruitingNCT03673787Phase 1/2
- Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing GlioblastomaCompletedNCT03665545Phase 1/2
- Treatment Intensification With Temozolomide in Adults With a GlioblastomaActive, not recruitingNCT03663725Phase 3
- A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96Status unknownNCT03650257Phase 2
- Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsWithdrawnNCT03649464Phase 1/2
- MRI Predictors of Response to Tumor Treating FieldsStatus unknownNCT03642080
- Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade GliomaStatus unknownNCT03633552Phase 3
- Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent GlioblastomaStatus unknownNCT03631836Phase 1
- Gut Microbiota and Glioblastoma Multiforme PrognosisStatus unknownNCT03631823
- Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBMCompletedNCT03630289Not applicable
- Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) PatientsCompletedNCT03626896Not applicable
- Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With GlioblastomaCompletedNCT03619239Phase 1
- GC1118 in Recurrent Glioblastoma Patients With High EGFR AmplificationCompletedNCT03618667Phase 2
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of GliomaCompletedNCT03616860Not applicable
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade GliomasCompletedNCT03603379Phase 1
- A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent GliomasTerminatedNCT03593993
- OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed GlioblastomaActive, not recruitingNCT03587038Phase 1
- Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab TreatmentTerminatedNCT03573986Phase 1
- Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for GlioblastomaStatus unknownNCT03567135
- 3D Prediction of Patient-Specific ResponseStatus unknownNCT03561207
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) DisruptionCompletedNCT03551249Not applicable
- [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy VolunteersTerminatedNCT03539731Phase 1
- Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT03535350Phase 1
- TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed GlioblastomaCompletedNCT03529448Phase 1/2
- Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and GlioblastomaCompletedNCT03514069Phase 1
- Biologically-based Target Volumes to Treat Newly Diagnosed GlioblastomaWithdrawnNCT03506139Phase 2
- Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating FieldsCompletedNCT03501134
- INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)Active, not recruitingNCT03491683Phase 1/2
- In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With GlioblastomaCompletedNCT03481231
- Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)WithdrawnNCT03480867Phase 1
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasActive, not recruitingNCT03478462Phase 1
- Personalized Radiation Therapy for GBMCompletedNCT03477513Not applicable
- Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With GlioblastomaCompletedNCT03477110Early Phase 1
- Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed GlioblastomaCompletedNCT03466450Phase 1/2
- Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)Status unknownNCT03463733Phase 1
- An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and GliomasNo longer availableNCT03460782
- Easing Psychosocial Burden for Informal CaregiversCompletedNCT03454295Early Phase 1
- Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated GlioblastomaCompletedNCT03452930Phase 1
- Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With GlioblastomaCompletedNCT03451799Phase 1
- Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With GlioblastomaCompletedNCT03439332
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerCompletedNCT03423628Phase 1
- Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated GlioblastomaTerminatedNCT03422094Phase 1
- Multi-parametric MRI/Fluorine-18 Fluciclovine PET-CT in GlioblastomaStatus unknownNCT03409549
- Prognosis and Therapeutic Biomarkers for Glioblastoma PatientsTerminatedNCT03403803
- Multi-site Validation and Application of a Consensus DSC-MRI ProtocolStatus unknownNCT03401866Not applicable
- Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed GlioblastomaStatus unknownNCT03400917Phase 2
- Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed GlioblastomaActive, not recruitingNCT03395587Phase 2
- Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)Status unknownNCT03392545Phase 1
- Exercise in Patients With GlioblastomaCompletedNCT03390569Not applicable
- Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV GliomaActive, not recruitingNCT03389230Phase 1
- Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral GlioblastomaCompletedNCT03388372Phase 2
- Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsTerminatedNCT03382977Phase 1/2
- A Trial of KB004 in Patients With GlioblastomaCompletedNCT03374943Phase 1
- FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing RadiotherapyStatus unknownNCT03370926
- Vaccine Therapy in Treating Patients With Recurrent GlioblastomaCompletedNCT03360708Early Phase 1
- A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)CompletedNCT03355794Phase 1
- Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma MultiformeStatus unknownNCT03347097Early Phase 1
- Phase I EGFR BATs in Newly Diagnosed GlioblastomaCompletedNCT03344250Phase 1
- Avelumab With Laser Interstitial Therapy for Recurrent GlioblastomaCompletedNCT03341806Phase 1
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2TerminatedNCT03332355Phase 1
- Expanded Access for Pembrolizumab (MK-3475)No longer availableNCT03311542
- Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma MultiformeCompletedNCT03310372Phase 2
- Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRIActive, not recruitingNCT03297125
- Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma PatientsStatus unknownNCT03294486Phase 1/2
- Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)CompletedNCT03294434
- Spectral Analysis Probe to Identify Glioblastoma CellsTerminatedNCT03293888
- 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma MultiformeCompletedNCT03291990Early Phase 1
- Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)CompletedNCT03291977Phase 3
- Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent GlioblastomaCompletedNCT03291314Phase 2
- Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed GlioblastomaTerminatedNCT03287063